Efficacy and safety of ustekinumab in Chinese patients with moderate to severe plaque-type psoriasis: results from a phase 3 clinical trial (LOTUS).

Journal of drugs in dermatology: JDD, 2013 - europepmc.org
Efficacy and safety of ustekinumab in Chinese patients with moderate to severe plaque-type
psoriasis: results from a phase 3 clinical trial (LOTUS). - Abstract - Europe PMC Sign in …
被引用次数：95 相关文章

Efficacy and safety of ustekinumab in Chinese patients with moderate to severe plaque-type psoriasis: results from a phase 3 clinical trial (LOTUS)

X Zhu, M Zheng, M Song, YK Shen… - Journal of drugs in …, 2013 - pubmed.ncbi.nlm.nih.gov
Background Available biologic agents for the treatment of psoriasis in China are limited.
Objectives The LOTUS study is a phase 3, double-blind, placebo-controlled study that …